Furthermore, while the role of intact PTH (i-PTH) in CKD-MBD management is well-established [6, 7], its impact on bone microarchitecture, particularly in a dialysis setting, has not been sufficiently explored. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.